NeuroBo Pharmaceuticals is a clinical-stage company that provides therapies for various illnesses such as neurodegenerative, infectious, and cardiometabolic diseases. They have programs such as ANA001, NB-01, NB-02, and Gemcabene, all of which aim to treat specific ailments such as painful diabetic neuropathy, COVID-19, and symptoms of cognitive impairment. The headquarters of NeuroBo Pharmaceuticals is located in Boston, Massachusetts.